SCHEMBL30863430

SCHEMBL30863430

COc1cc(NC(=O)c2ccc(OCCN(C)C)cc2)c2cnccc2c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 2/20 0.49
▸ ABL1 P00519 2/20 0.49
▸ BCR P11274 2/20 0.49
▸ MAPT P10636 2/20 0.45
▸ MEN1 O00255 1/20 0.45
▸ TSHR P16473 1/20 0.44
▸ MAPK1 P28482 1/20 0.44
▸ HDAC1 Q13547 2/20 0.44
▸ CACNA1H O95180 2/20 0.44
▸ DRD2 P14416 2/20 0.44
▸ DRD3 P35462 2/20 0.44
▸ HRH3 Q9Y5N1 1/20 0.44
▸ CACNA1B Q00975 1/20 0.44
▸ CHRNB2 P17787 1/20 0.43
▸ CHRNB4 P30926 1/20 0.43
▸ CHRNA3 P32297 1/20 0.43
▸ CHRNA4 P43681 1/20 0.43
▸ LMNA P02545 2/20 0.43
▸ STAT3 P40763 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27195725 0.92 KMT2A (0.49) KMT2AABL1BCRMAPTMEN1
SCHEMBL30863554 0.92 KMT2A (0.49) KMT2AABL1BCRMAPTMEN1
Hydrochloric Acid SCHEMBL30863526 0.91 KMT2A (0.48) KMT2AABL1BCRMAPTMEN1
SCHEMBL27195708 0.85 CACNA1H (0.51) KMT2AABL1BCRHDAC1CACNA1H
SCHEMBL30863474 0.81 ABL1 (0.51) ABL1BCRMAPTTSHRMAPK1
SCHEMBL27195981 0.81 ABL1 (0.51) ABL1BCRMAPTTSHRMAPK1
SCHEMBL27195733 0.79 TRPV1 (0.59) KMT2AMAPTMEN1MAPK1HDAC1
SCHEMBL30863471 0.78 CACNA1H (0.48) ABL1BCRHDAC1CACNA1HHRH3
SCHEMBL27195800 0.78 CACNA1H (0.48) ABL1BCRHDAC1CACNA1HHRH3
SCHEMBL27195732 0.78 CACNA1H (0.48) ABL1BCRHDAC1CACNA1HHRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4581017-A1 NEW N-HETEROARYLBENZAMIDES DERIVATIVES AS FLT3 INHIBITORS Biodol Therapeutics (FR) 2025-07-09 — — EP claimed
WO-2024079072-A1 NEW N-HETEROARYLBENZAMIDES DERIVATIVES AS FLT3 INHIBITORS BIODOL THERAPEUTICS (FR) 2024-04-18 — — WO claimed
EP-4581017-A1 NEW N-HETEROARYLBENZAMIDES DERIVATIVES AS FLT3 INHIBITORS Biodol Therapeutics (FR) 2025-07-09 — — EP disclosed
WO-2024079072-A1 NEW N-HETEROARYLBENZAMIDES DERIVATIVES AS FLT3 INHIBITORS BIODOL THERAPEUTICS (FR) 2024-04-18 — — WO disclosed
Send feedback